本页面由Tiger Trade Technology Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

21.42
+0.04500.21%
成交量:34.39万
成交额:736.09万
市值:22.12亿
市盈率:-20.59
高:21.42
开:21.38
低:21.38
收:21.37
52周最高:21.44
52周最低:5.64
股本:1.03亿
流通股本:7,876.62万
量比:1.28
换手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-1.0400
每股收益(LYR):-1.0400
净资产收益率:-22.74%
总资产收益率:-14.64%
市净率:5.01
市盈率(LYR):-20.59

数据加载中...

2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/06

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities